CGEN vs CERS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 25, 2026

CGEN

48.0
AI Score
VS
CERS Wins

CERS

69.7
AI Score

Investment Advisor Scores

CGEN

48score
Recommendation
HOLD

CERS

70score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CGEN CERS Winner
Forward P/E 12.3609 0 Tie
PEG Ratio 1.2874 0 Tie
Revenue Growth 107.0% 9.5% CGEN
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 48.0/100 69.7/100 CERS
Profit Margin 47.6% -3.1% CGEN
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY CERS

Relative Price Performance (Last 90 Days)

CGEN 1M: -15.5% · 3M: -12.1% CERS 1M: -2.0% · 3M: -16.4%

Current Technical Phase

CGEN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.3%), weak momentum, RSI 40

RSI (14): 39.6 · Price: $1.97

CERS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.5 · Price: $2.40

Fundamentals Snapshot

Metric CGEN CERS
Market Cap — —
Forward P/E -5.4 -480.0
Trailing P/E 4.9 —
Revenue (TTM) — —
Revenue Growth 1.1% 0.1%
Gross Margin 0.9% 0.5%
Operating Margin -3.4% 0.0%
EPS 0.38 -0.03
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CERS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.